Benzinga Rankings give you vital metrics on any stock – anytime.
Explore First Trust Amex Biotech Index Fund stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for FBT.
Open | - |
High | - |
52 Wk High | $183.60 |
AUM | 996.61M |
Dividend | $4.69 |
Ex-Div Date | Dec 13, 2024 |
Volume | - |
Market Cap | $25.32B |
Mgmt Fee | 0.4% |
P/E Ratio | 24.31 |
Prev. Close | $152.03 |
Low | - |
52 Wk Low | $140.36 |
Shares Out | 7.55M |
Yield | 3.09% |
Div. Freq | Quarterly |
Avg. Volume Daily | 23.76K |
Beta | 0.69 |
Avg. Expense Ratio | 0.56% |
P/B Ratio | 4.34 |
You can purchase shares of First Trust Amex Biotech Index Fund (ARCA:FBT) through any online brokerage.
There are no as such competitors for First Trust Amex Biotech Index Fund.
There is no analysis for First Trust Amex Biotech Index Fund to provide a consensus price target.
The stock price for First Trust Amex Biotech Index Fund (ARCA: FBT) is $152.0302 last updated April 11, 2025 at 8:00 PM EDT.
A quarterly cash dividend of 1.17 per share of Class A Common Stock. The quarterly cash dividend was payable on December 31, 2024 to stockholders of record on December 13, 2024.
First Trust Amex Biotech Index Fund does not have any upcoming earnings scheduled.
There is no upcoming split for First Trust Amex Biotech Index Fund.
Open | - |
High | - |
52 Wk High | $183.60 |
AUM | 996.61M |
Dividend | $4.69 |
Ex-Div Date | Dec 13, 2024 |
Volume | - |
Market Cap | $25.32B |
Mgmt Fee | 0.4% |
P/E Ratio | 24.31 |
Prev. Close | $152.03 |
Low | - |
52 Wk Low | $140.36 |
Shares Out | 7.55M |
Yield | 3.09% |
Div. Freq | Quarterly |
Avg. Volume Daily | 23.76K |
Beta | 0.69 |
Avg. Expense Ratio | 0.56% |
P/B Ratio | 4.34 |
Sector | Healthcare |
Category | Short Term Safe |
Investment Style | Mid Cap Growth |
Fund Inception | Jun 19, 2006 |
Managers | Stan Ueland David G. McGarel Daniel J. Lindquist Roger F. Testin Erik Russo Chris A. Peterson Jon C. Erickson |
Definition | Fixed income fund portfolio contains a large percentage of securities with low duration and superior credit quality |
Symbol | Name | Share % |
---|---|---|
RGEN | Repligen Corp | 4.27% |
EXAS | Excat Scienece Corpora... | 3.99% |
ALKS | Alkermes Plc | 4.02% |
CORT | Corcept Therapeutics I... | 6.40% |
BGNE | Beigene, Ltd. Adr | 5.32% |
WAT | Waters Corp. | 3.60% |
GILD | Gilead Sciences Inc | 4.30% |
EXEL | Exelixis | 3.51% |
AS | Argenx Se Spon Adr Eac... | 3.44% |
ACAD | Acadia Pharmaceuticals... | 3.70% |
ITCI | Intra-Cellular Therapi... | 4.82% |
AMGN | Amgen Inc. | 4.06% |
VRTX | Vertex Pharmaceuticals... | 4.11% |
HALO | Halozyme Therapeutics ... | 4.07% |
ALNY | Alnylam Pharmaceutical... | 3.73% |